Gene therapy for platelet disorders: studies with Glanzmann's thrombasthenia
- 1 November 2003
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (11) , 2300-2311
- https://doi.org/10.1046/j.1538-7836.2003.00476.x
Abstract
No abstract availableKeywords
This publication has 129 references indexed in Scilit:
- Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIIIJournal of Thrombosis and Haemostasis, 2003
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Crystal Structure of the Extracellular Segment of Integrin αVβ3Science, 2001
- An Anthropomorphic IntegrinScience, 2001
- Engraftment of Hematopoietic Progenitor Cells Transduced with the Fanconi Anemia Group C Gene (FANCC)Human Gene Therapy, 1999
- Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex.Journal of Clinical Investigation, 1997
- Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosisCardiovascular Research, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- A Comparative Analysis of cDNA-Derived Sequences for Rat and Mouse β3 Integrins (GPIIIA) with Their Human CounterpartBiochemical and Biophysical Research Communications, 1993
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992